Using PET/CT with 18F-fluorodeoxyglucose–labeled leukocytes is a noninvasive and reliable method to help diagnose acute pancreatitis.
PET plus CT with 18F-fluorodeoxyglucose (FDG)–labeled leukocytes can be used to diagnose infection in pancreatic or peripancreatic fluid collections in patients with acute pancreatitis (AP), according to a study published in The Journal of Nuclear Medicine.
Researchers from India undertook a study to determine if using PET/CT with 18F-FDG–labeled leukocytes for early detection of AP could affect the choice of treatment and clinical outcomes of patients who had acute pancreatitis.
The study included 28 men and 13 women, mean age 41. All were diagnosed with AP and had radiologic evidence of fluid collection in or around the pancreas. The radiotracer 18F-FDG was added to leukocytes that had been separated from the patients’ venous blood, and then was intravenously administered back to the patient. The patients then underwent PET/CT imaging two hours after receiving the radiotracer. Final diagnosis of AP was based on microbiologic culture of fluid aspirated from the collection.
Results:
There was an increased tracer uptake in the fluid collection in 12 of 41 patients. Ten patients had culture-proven infection and underwent percutaneous drainage. Aspiration was unsuccessful in two. “The scan results were negative for infection in 29 patients; 25 had fluid culture results that were negative for infection, and aspiration was unsuccessful in four,” the authors wrote. “The sensitivity, specificity, and accuracy of the scan were all 100 percent in 35 patients for whom fluid culture reports were available.”
The authors concluded that PET/CT with 18F-FDG–labeled leukocytes is both a noninvasive and reliable method for the diagnosis of infection in pancreatic or peripancreatic fluid collections in patients with AP.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).